← back to search

Jin‐Ju Kim

University of Miami · US
Area of research
Nephrology · Immunology and Allergy
Research interest
Research interests include Renal Diseases and Glomerulopathies, Cell Adhesion Molecules Research, Chronic Kidney Disease and Diabetes, and Renal and related cancers.
h-index
25
citations
2,392
works
104
NIH funding
primary concept
email

Recent publications

From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome
Pediatric Nephrology 2025cited by 2position: middledoi
Ezetimibe Enhances Lipid Droplet and Mitochondria Contact Formation, Improving Fatty Acid Transfer and Reducing Lipotoxicity in Alport Syndrome Podocytes
International Journal of Molecular Sciences 2024cited by 12position: firstdoi
Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome
eLife 2023cited by 59position: middledoi
ABCA1 deficiency contributes to podocyte pyroptosis priming via the APE1/IRF1 axis in diabetic kidney disease
Scientific Reports 2023cited by 16position: middledoi
Activation of Stimulator of IFN Genes (STING) Causes Proteinuria and Contributes to Glomerular Diseases
Journal of the American Society of Nephrology 2022cited by 75position: middledoi
APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis
Human Molecular Genetics 2021cited by 46position: middledoi
Podocyte Lipotoxicity in CKD
Kidney360 2021cited by 31position: firstdoi
Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome
EBioMedicine 2020cited by 56position: firstdoi
Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome
Kidney International 2020cited by 55position: middledoi
ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes
Journal of Clinical Investigation 2019cited by 174position: middledoi
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
Nature Communications 2019cited by 98position: middledoi
DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome
ACS Chemical Biology 2018cited by 113position: middledoi
Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis
Kidney International 2018cited by 87position: middledoi
Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance
Journal of Clinical Investigation 2014cited by 165position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alessia Fornoni · University of Miami9 papers (2018–2024)Sandra Merscher · University of Miami9 papers (2018–2024)Shamroop Kumar Mallela · University of Miami8 papers (2018–2023)Javier Varona-Santos · University of Miami8 papers (2018–2023)Alla Mitrofanova · University of Miami8 papers (2018–2023)Mengyuan Ge · University of Miami8 papers (2018–2023)Alexis Sloan · University of Miami7 papers (2018–2024)Judith Molina · University of Miami Hospital6 papers (2018–2023)Gloria Michelle Ducasa · University of Miami6 papers (2018–2023)Armando J. Mendez · University of Miami4 papers (2018–2021)Judith Molina David · University of Miami3 papers (2020–2024)Sydney S. Wilbon · University of Miami3 papers (2020–2021)Antonio Miguel Fontanella · University of Miami3 papers (2020–2024)Hassan Al‐Ali · University of Miami3 papers (2020–2023)Matthias Kretzler · University of Bristol3 papers (2018–2022)George W. Burke · University of Miami3 papers (2018–2022)Robert G. Nelson · Institute of Nutrition, Metabolism and Diabetes3 papers (2019–2022)Flavia Fontanesi · University of Miami3 papers (2019–2023)Xiaochen Liu · University of Miami3 papers (2019–2021)Gabriel Contreras · University of Miami2 papers (2020–2020)